vs

Side-by-side financial comparison of Lucid Diagnostics Inc. (LUCD) and QMMM Holdings Ltd (QMMM). Click either name above to swap in a different company.

QMMM Holdings Ltd is the larger business by last-quarter revenue ($2.0M vs $1.2M, roughly 1.7× Lucid Diagnostics Inc.). QMMM Holdings Ltd runs the higher net margin — -7.1% vs -858.5%, a 851.4% gap on every dollar of revenue.

Lucid Diagnostics Inc. is a commercial-stage medical diagnostics firm focused on non-invasive screening tests for upper gastrointestinal diseases, including early detection of esophageal cancer and pre-cancerous lesions. It mainly serves healthcare providers and clinical partners across the United States, targeting at-risk patient populations.

LUCD vs QMMM — Head-to-Head

Bigger by revenue
QMMM
QMMM
1.7× larger
QMMM
$2.0M
$1.2M
LUCD
Higher net margin
QMMM
QMMM
851.4% more per $
QMMM
-7.1%
-858.5%
LUCD

Income Statement — Q3 FY2025 vs Q2 FY2025

Metric
LUCD
LUCD
QMMM
QMMM
Revenue
$1.2M
$2.0M
Net Profit
$-10.4M
$-146.1K
Gross Margin
27.1%
Operating Margin
-971.0%
-6.5%
Net Margin
-858.5%
-7.1%
Revenue YoY
3.3%
Net Profit YoY
16.0%
EPS (diluted)
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LUCD
LUCD
QMMM
QMMM
Q3 25
$1.2M
Q2 25
$1.2M
Q1 25
$828.0K
$2.0M
Q4 24
$1.2M
Q3 24
$1.2M
Q2 24
$976.0K
Q1 24
$1.0M
$1.3M
Q4 23
$1.0M
Net Profit
LUCD
LUCD
QMMM
QMMM
Q3 25
$-10.4M
Q2 25
$-4.4M
Q1 25
$-26.9M
$-146.1K
Q4 24
$-11.5M
Q3 24
$-12.4M
Q2 24
$-11.0M
Q1 24
$-10.6M
$-612.0K
Q4 23
$-10.8M
Gross Margin
LUCD
LUCD
QMMM
QMMM
Q3 25
Q2 25
Q1 25
27.1%
Q4 24
Q3 24
Q2 24
Q1 24
24.1%
Q4 23
Operating Margin
LUCD
LUCD
QMMM
QMMM
Q3 25
-971.0%
Q2 25
-978.8%
Q1 25
-1508.1%
-6.5%
Q4 24
-1033.8%
Q3 24
-997.8%
Q2 24
-1146.7%
Q1 24
-1078.1%
-46.2%
Q4 23
-1101.3%
Net Margin
LUCD
LUCD
QMMM
QMMM
Q3 25
-858.5%
Q2 25
-381.7%
Q1 25
-3249.8%
-7.1%
Q4 24
-964.2%
Q3 24
-1055.5%
Q2 24
-1127.6%
Q1 24
-1060.1%
-45.5%
Q4 23
-1041.3%
EPS (diluted)
LUCD
LUCD
QMMM
QMMM
Q3 25
$-0.10
Q2 25
$-0.08
Q1 25
$-0.52
Q4 24
$-0.17
Q3 24
$-0.25
Q2 24
$-0.23
Q1 24
$-0.40
Q4 23
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LUCD
LUCD
QMMM
QMMM
Cash + ST InvestmentsLiquidity on hand
$47.3M
$167.9K
Total DebtLower is stronger
Stockholders' EquityBook value
$25.8M
$3.9M
Total Assets
$53.2M
$4.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LUCD
LUCD
QMMM
QMMM
Q3 25
$47.3M
Q2 25
$31.1M
Q1 25
$25.2M
$167.9K
Q4 24
$22.4M
Q3 24
$14.5M
Q2 24
$24.9M
Q1 24
$24.8M
$218.9K
Q4 23
$18.9M
Stockholders' Equity
LUCD
LUCD
QMMM
QMMM
Q3 25
$25.8M
Q2 25
$7.9M
Q1 25
$-5.4M
$3.9M
Q4 24
$5.4M
Q3 24
$6.3M
Q2 24
$16.0M
Q1 24
$11.9M
$-1.1M
Q4 23
$-2.3M
Total Assets
LUCD
LUCD
QMMM
QMMM
Q3 25
$53.2M
Q2 25
$38.7M
Q1 25
$32.8M
$4.5M
Q4 24
$30.7M
Q3 24
$22.6M
Q2 24
$34.1M
Q1 24
$32.0M
$1.3M
Q4 23
$27.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LUCD
LUCD
QMMM
QMMM
Operating Cash FlowLast quarter
$-10.9M
$-301.2K
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LUCD
LUCD
QMMM
QMMM
Q3 25
$-10.9M
Q2 25
$-10.5M
Q1 25
$-12.5M
$-301.2K
Q4 24
$-9.9M
Q3 24
$-10.2M
Q2 24
$-11.5M
Q1 24
$-12.6M
$-184.6K
Q4 23
$-10.0M

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons